EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham Titelbild

EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham

EP 165: Harnessing CRISPR and RNA editing to transform healthcare with Dr. Ness Bermingham

Jetzt kostenlos hören, ohne Abo

Details anzeigen

Über diesen Titel

 In this episode, we’re joined by Dr. Ness Bermingham, Operating Partner at Khosla Ventures and Chair of the Board at Korro Bio. A scientist-turned-biotech entrepreneur, Ness is passionate about the power of science to tackle some of healthcare’s biggest challenges. Ness co-founded Intellia Therapeutics, a leader in CRISPR gene editing, and Korro Bio, an innovator in RNA editing, driving breakthroughs that translate cutting-edge science into real healthcare solutions. With over 20 years of experience in biotech and healthcare, he’s played a vital role in shaping startups into companies that develop life-changing medicines. Tune in as we dive into Ness’s journey and his insights on innovation in biotech!
Noch keine Rezensionen vorhanden